Allergan Prepares Takeover Bid for Shire

Allergan Inc., facing an unsolicited bid from Valeant Pharmaceuticals International Inc., is preparing to approach Shire Plc about a potential takeover, even though the Irish drugmaker rebuffed a previous overture, according to a Reuters article. A bid by Allergan for Shire, which has a market value of $32 billion, would show how determined the U.S. dermatology drugmaker is to stay independent. Read the full story

More News:

All news »

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments